Open Label, Single-Center, Phase 1 Clinical Study to Evaluate the Safety and the Efficacy of PNEUMOSTEM Treatment in Premature Infants With Bronchopulmonary Dysplasia

Trial Profile

Open Label, Single-Center, Phase 1 Clinical Study to Evaluate the Safety and the Efficacy of PNEUMOSTEM Treatment in Premature Infants With Bronchopulmonary Dysplasia

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Jan 2014

At a glance

  • Drugs Mesenchymal stem cell therapy (Primary)
  • Indications Bronchopulmonary dysplasia
  • Focus Adverse reactions
  • Sponsors Medipost
  • Most Recent Events

    • 02 Dec 2013 Extension study details added.
    • 30 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top